Premium
Acumen Pharmaceuticals Inc (ABOS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets... Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.22 | -16.0583941606 | 1.37 | 1.39 | 1.15 | 234470 | 1.27457333 | CS |
| 4 | -0.33 | -22.2972972973 | 1.48 | 1.55 | 1.15 | 246113 | 1.38031383 | CS |
| 12 | -1.07 | -48.1981981982 | 2.22 | 2.24 | 1.15 | 325850 | 1.67709502 | CS |
| 26 | -1.3 | -53.0612244898 | 2.45 | 3.36 | 1.15 | 257235 | 2.05900849 | CS |
| 52 | -3.85 | -77 | 5 | 5.09 | 1.15 | 283535 | 2.6825192 | CS |
| 156 | -4.3 | -78.8990825688 | 5.45 | 11.3099 | 1.15 | 432897 | 6.03850447 | CS |
| 260 | -23.92 | -95.4128440367 | 25.07 | 26.98 | 1.15 | 387017 | 6.52382588 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
